Comparative, Multicenter Study in Subjects with Rheumatoid Arthritis, ALVOFLEX
NCT05842213
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
502
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL:
AVT05 (proposed biosimilar to golimumab)
BIOLOGICAL:
Simponi (Golimumab)
Sponsor
Alvotech Swiss AG